A Pilot Study: Self-Empowerment Therapy for Depression Associated with PTSD
Biomedical Science and Clinical Research · 2022
DOI: 10.33140/bscr.01.01.07 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Science and Clinical Research, 2022.
Themen: Depression
Abstract (Originalsprache)
Background
Mental Health issues such as depression, PTSD, suicide etc., have become epidemics crippling western society requiring significant allocation of funds to address them. Research shows that that regardless of therapy used, nature and severity of the presenting problem and diagnosis, the modal frequency of patients attending counselling services is 1 [1-3]. With this in mind, Self-Empowerment Therapy (SET) was developed by the author [4].
Aims
The aim of this study was to look at effectiveness of SET as a single session in the treatment of depression.
Method
A cohort of 82 subjects were assessed using the Beck Depression Inventory at the start of the single-session and at the conclusion of the single-session. Single session SET consisting of recording baseline measures, administration of 4 clinical exercises, questionnaire administration and results analysis.
Results
Results of the tests showed (n=82) showed clinically significant therapeutic effects from SET in a single therapy session with 76.82 percent improvement.
Conclusions
Results for the in-person single shot two hour SET depression intervention demonstrated clinically significant impact on depression symptoms associated with PTSD.
Zitieren
APA
(2022). A Pilot Study: Self-Empowerment Therapy for Depression Associated with PTSD. Biomedical Science and Clinical Research. https://doi.org/10.33140/bscr.01.01.07
Vancouver
A Pilot Study: Self-Empowerment Therapy for Depression Associated with PTSD. Biomedical Science and Clinical Research. 2022. doi:10.33140/bscr.01.01.07
BibTeX
@article{euvimed2022,
title = {A Pilot Study: Self-Empowerment Therapy for Depression Associated with PTSD},
journal = {Biomedical Science and Clinical Research},
year = {2022},
doi = {10.33140/bscr.01.01.07}
}
EUVIMED